Clinical advantages of two vs. three courses of neoadjuvant chemotherapy using docetaxel + cisplatin + 5-fluorouracil to improve preoperative nutritional status and mitigate decreasing skeletal muscle in resectable esophageal cancer

Kazuaki Matsui(Keio University), Shinichi Sakuramoto(Saitama Medical University), Gen Ebara(Saitama Medical University), Masatoshi Yoshizawa(Saitama Medical University), Yutaka Miyawaki(Saitama Medical University), Hiroshi Sato, Tetsuro Toriumi(Saitama Medical University), Ryota Kobayashi(Teikyo University of Science)
International Journal of Clinical Oncology
July 17, 2025
Cited by 0


Related Papers